Describe the role of INR monitoring in anticoagulation therapy and explain the need for bridge therapy with warfarin. (SIGS 6.1a)
monitor coagulability (maintain optimal level- not too low or too high); Bridge therapy for warfarin due to taking several days to achieve therapeutic effects
Oops!
Check
Okay!
Check
15
Correlate hyperlipidemia with the development of atherosclerotic plaques in blood vessels. (SIGS 6.3a)โฏ
Describe the potential benefits and precautions for the use of CoQ10 and L-carnitine for cardiac function. (SIGS 6.3b)
CoQ10: facilitates ATP production via ETC in mitochondria; body can become dependant- do not stop abruptly; L-Carn.: "shuttle" for FA to mitochondria in L vent.
Oops!
Check
Okay!
Check
15
Describe the pathogenesis of coxsackievirus type B and how it relates to viral myocarditis. (Sigs Case 6.2a)
GI tract (stable at low gI pH)โinfects mucosal epithelial cellsโviremiaโinfects + lyse heart/pleural surfaces
Oops!
Check
Okay!
Check
15
Explain the mechanism of action of amiodarone and the rationale for its use in dysrhythmias. (SIGS 6.2b)
Class III anti-arryth; MOA: blocks VG K+ channels --> inhibit Phase 3 repol--> prolong cardiac action potential & refractoriness--> decr. SA node firing rate
Oops!
Check
Okay!
Check
15
What is the MOA of Colchicine and how does it relate to the management of pericarditis?(Sigs Case 6.2a)
used as a theoretical anti-inflamm. agent; inhibits IL-1 from cascading, interferes w/ NFK-B; binds to microtubular tubulin in neutrophils-> inhibits mitosis
Oops!
Check
Okay!
Check
15
Discuss the use of ACE-inhibitors and beta-blockers to slow or reverse cardiac remodeling. (Sigs Case 6.2a)
ACE-inh.: allows heart to get more blood flow & decrease LV filing & decreases peripheral resistance; BB: decreases demand on heart and lowers BP